Article
FasL expression in cardiomyocytes activates the ERK1/2 pathway, leading to dilated cardiomyopathy and advanced heart failure.
Clinical science (London, England : 1979) - 1 Feb 2016
Huby Anne-Cecile, Turdi Subat, James Jeanne, Towbin Jeffrey A, Purevjav Enkhsaikhan
Abstract excerpt
Increase in the apoptotic molecule Fas ligand (FasL) in serum and cardiomyocytes has been shown to be associated with progressive dilated cardiomyopathy (DCM) and congestive heart failure (CHF) in humans. However, the underlying mechanism(s) of FasL-related deterioration of heart function remain obscure. The aim of the present study is to determine roles of myocardial FasL in the activation of alternative...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
